HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Wednesday, 22 July 2015

Recently published CEAs

Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers.  From the ones listed this time, here's a few in our areas of research interest:

Pandya A, Sy S, Cho S, et. al. Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular Disease. JAMA. 2015 Jul 14;314(2):142-50. doi: 10.1001/jama.2015.6822. PubMed PMID: 26172894.

Vallejo-Torres L, Castilla I, Couce ML, et. al. Cost-Effectiveness Analysis of a National Newborn Screening Program for Biotinidase Deficiency. Pediatrics. 2015 Jul 13. [Epub ahead of print] PubMed PMID: 26169436.

Li R, Qu S, Zhang P, Chattopadhyay S, et. al. Economic Evaluation of Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force. Ann Intern Med. 2015 Jul 14. [Epub ahead of print] PubMed PMID: 26167962.

Campbell JR, Sasitharan T, Marra F. A Systematic Review of Studies Evaluating the Cost Utility of Screening High-Risk Populations for Latent Tuberculosis Infection. Appl Health Econ Health Policy. 2015 Jul 1. [Epub ahead of print] PubMed PMID: 26129810.

Quartuccio L, di Bidino R, Ruggeri M, et. al. Cost-Effectiveness Analysis of Two Rituximab Retreatment Regimens for Longstanding Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2015 Jul;67(7):947-55. PubMed PMID: 25581074.